Skip to main content
ARGX
NASDAQ Life Sciences

Efgartigimod Delivers Sustained Long-Term Benefit in Myositis, Sjogren's Disease

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$802.17
Mkt Cap
$51.667B
52W Low
$510.055
52W High
$934.62
52W Position info
57% above low
Off High info
14% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ARGX sits 57% above its 52-week low of $510.055.

Summary

ARGENX presented new positive clinical data for its drug efgartigimod (VYVGART) at EULAR 2026, showing long-term sustained patient benefit in myositis and Sjogren's disease. Data from open-label extension studies (ALKIVIA+ and RHO+) indicated consistent safety and clinically meaningful improvements, with 37.5% of myositis patients maintaining major improvement at 52 weeks. This reinforces the drug's efficacy and safety profile, potentially expanding its market opportunity in autoimmune diseases. This follows a period of strong financial results and an expanded FDA label for VYVGART. Topline results from the Phase 3 ALKIVIA study for myositis are expected in the third quarter of 2026.

At the time of this announcement, ARGX was trading at $802.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $51.7B. The 52-week trading range was $510.06 to $934.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ARGX - Latest Insights

ARGX
Oct 22, 2026, 8:20 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $854.00
Real-time Price: $894.77 info
Change: +$40.77 (+5%) info
Market Cap: $57.544B info
ARGX
Oct 08, 2026, 6:51 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $795.20
Real-time Price: $894.77 info
Change: +$99.57 (+13%) info
Market Cap: $57.544B info
ARGX
Oct 08, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $791.00
Real-time Price: $894.77 info
Change: +$103.77 (+13%) info
Market Cap: $57.544B info
ARGX
Sep 29, 2026, 8:38 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $970.55
Real-time Price: $894.77 info
Change: -$75.78 (-8%) info
Market Cap: $57.544B info
ARGX
Aug 27, 2026, 9:27 AM EDT
Filing Type: SC TO-T/A
Importance Score:
8
Price at Filing: $1,018.58
Real-time Price: $894.77 info
Change: -$123.81 (-12%) info
Market Cap: $57.544B info